FindTrial
Sign In

Incidence of postoperative pharyngolaryngeal adverse events with LMA Supreme at high and low intracuff pressures

Incidence of postoperative pharyngolaryngeal adverse events with LMA Supreme at high and low intracuff pressures

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000334
Enrollment
120
Registered
2012-02-01
Start date
2012-01-03
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Konkuk University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing laparoscopic surgical procedures were enrolled and written informed consent was obtained.

Exclusion criteria

Exclusion criteria: Patients were excluded if the following criteria present: 1)known or predicted difficult airway, 2)vocal cord paralysis, 3)recent history of respiratory infection (within 1 month), 4)neurological deficits or psychiatric disorders, 5)history of drug abuse, 6)receiving current medications, 7)allergy to egg or soybean oil, 8)contraindications for use of LMA.

Design outcomes

Primary

MeasureTime frame
sore throat—

Secondary

MeasureTime frame
dysphagia; dysphonia—

Countries

Korea, Republic of

Contacts

Public ContactJooeun Kang

Konkuk University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 8, 2026